Sedana Medical AB (publ) (SEDANA.ST)
SEK 8.24
(-0.48%)
SEK 8.24
(-0.48%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 42.97 Million SEK | 11.34% |
| 2022 | 38.59 Million SEK | 247.94% |
| 2021 | 11.09 Million SEK | 22.08% |
| 2020 | 9.08 Million SEK | 23.16% |
| 2019 | 7.37 Million SEK | 17.21% |
| 2018 | 6.29 Million SEK | 96.38% |
| 2017 | 3.2 Million SEK | -29.35% |
| 2016 | 4.53 Million SEK | 20.06% |
| 2015 | 3.77 Million SEK | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 38.46 Million SEK | -2.84% |
| 2024 Q1 | 39.59 Million SEK | -7.87% |
| 2024 Q3 | 39.46 Million SEK | 2.59% |
| 2023 Q3 | 48.55 Million SEK | 6.38% |
| 2023 Q4 | 42.97 Million SEK | -11.5% |
| 2023 FY | 42.97 Million SEK | 11.34% |
| 2023 Q1 | 38.86 Million SEK | 0.7% |
| 2023 Q2 | 45.64 Million SEK | 17.44% |
| 2022 FY | 38.59 Million SEK | 247.94% |
| 2022 Q2 | 32.35 Million SEK | 74.93% |
| 2022 Q3 | 34.97 Million SEK | 8.09% |
| 2022 Q4 | 38.59 Million SEK | 10.35% |
| 2022 Q1 | 18.49 Million SEK | 66.75% |
| 2021 Q1 | 11.73 Million SEK | 29.18% |
| 2021 Q2 | 10.71 Million SEK | -8.73% |
| 2021 FY | 11.09 Million SEK | 22.08% |
| 2021 Q4 | 11.09 Million SEK | -8.13% |
| 2021 Q3 | 12.07 Million SEK | 12.7% |
| 2020 Q1 | 6.03 Million SEK | -18.2% |
| 2020 FY | 9.08 Million SEK | 23.16% |
| 2020 Q4 | 9.08 Million SEK | -25.43% |
| 2020 Q3 | 12.18 Million SEK | 39.58% |
| 2020 Q2 | 8.73 Million SEK | 44.65% |
| 2019 Q4 | 7.37 Million SEK | 26.26% |
| 2019 FY | 7.37 Million SEK | 17.21% |
| 2019 Q1 | 4.16 Million SEK | -33.8% |
| 2019 Q2 | 5.8 Million SEK | 39.22% |
| 2019 Q3 | 5.84 Million SEK | 0.73% |
| 2018 Q4 | 6.29 Million SEK | 31.91% |
| 2018 FY | 6.29 Million SEK | 96.38% |
| 2018 Q1 | 5.2 Million SEK | 62.35% |
| 2018 Q2 | 4.88 Million SEK | -6.11% |
| 2018 Q3 | 4.77 Million SEK | -2.33% |
| 2017 Q3 | 2.8 Million SEK | -36.64% |
| 2017 Q2 | 4.43 Million SEK | -7.79% |
| 2017 FY | 3.2 Million SEK | -29.35% |
| 2017 Q4 | 3.2 Million SEK | 14.13% |
| 2017 Q1 | 4.8 Million SEK | 5.95% |
| 2016 Q4 | 4.53 Million SEK | 0.0% |
| 2016 FY | 4.53 Million SEK | 20.06% |
| 2015 FY | 3.77 Million SEK | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Acarix AB (publ) | 6.83 Million SEK | -528.381% |
| ADDvise Group AB (publ) | 121.2 Million SEK | 64.542% |
| ADDvise Group AB (publ) | 121.2 Million SEK | 64.542% |
| Arcoma AB | 28.02 Million SEK | -53.334% |
| Bactiguard Holding AB (publ) | 29.64 Million SEK | -44.961% |
| BICO Group AB (publ) | 493.1 Million SEK | 91.285% |
| Boule Diagnostics AB (publ) | 62.4 Million SEK | 31.13% |
| CellaVision AB (publ) | 126.03 Million SEK | 65.903% |
| Clinical Laserthermia Systems AB (publ) | 6.11 Million SEK | -602.78% |
| Chordate Medical Holding AB (publ) | 1.77 Million SEK | -2326.703% |
| C-Rad AB (publ) | 64.09 Million SEK | 32.956% |
| Duearity AB (publ) | 4.15 Million SEK | -933.301% |
| Dignitana AB (publ) | 7.41 Million SEK | -479.725% |
| Episurf Medical AB (publ) | 3.7 Million SEK | -1061.486% |
| Getinge AB (publ) | 6.41 Billion SEK | 99.33% |
| Scandinavian Real Heart AB (Publ) | -1.68 Million SEK | 2652.913% |
| Iconovo AB (publ) | -4.86 Million SEK | 983.896% |
| Integrum AB (publ) | 22.36 Million SEK | -92.179% |
| Luxbright AB (publ) | 8000.00 SEK | -537087.5% |
| Mentice AB (publ) | 14.1 Million SEK | -204.701% |
| OssDsign AB (publ) | 4.3 Million SEK | -898.49% |
| Paxman AB (publ) | 19.99 Million SEK | -114.886% |
| Promimic AB (publ) | 330 Thousand SEK | -12922.727% |
| Qlife Holding AB (publ) | 7.29 Million SEK | -489.344% |
| SciBase Holding AB (publ) | 11.91 Million SEK | -260.559% |
| ScandiDos AB (publ) | 22.69 Million SEK | -89.401% |
| Sectra AB (publ) | 36.59 Million SEK | -17.45% |
| Senzime AB (publ) | 20.34 Million SEK | -111.283% |
| SpectraCure AB (publ) | 1.00 SEK | -4297499900.0% |
| Stille AB | 66.55 Million SEK | 35.427% |
| Vitrolife AB (publ) | 413 Million SEK | 89.594% |
| Xvivo Perfusion AB (publ) | 141.6 Million SEK | 69.651% |